Paperpal Prime Logo

Pharmacoepidemiology and Drug Safety : Impact Factor & More

eISSN: 1099-1557pISSN: 1053-8569

Key Metrics

CiteScore
4
Impact Factor
< 5
SJR
Q2Epidemiology
SNIP
1.03
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Pharmacoepidemiology and Drug Safety

Pharmacoepidemiology and Drug Safety Journal Specifications

Overview
Publisher WILEY
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1992
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Pharmacoepidemiology and Drug Safety ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Pharmacoepidemiology and Drug Safety

Pharmacological Therapy in Patients With Gender Dysphoria: A Cohort Study in the Lazio Region, Italy.
  • 1 Aug 2026
  • Pharmacoepidemiology and drug safety
Prenatal Exposure to Modafinil and the Risk of Major Congenital Anomalies and Other Adverse Neonatal and Pediatric Outcomes
  • 1 Aug 2026
  • Pharmacoepidemiology and Drug Safety
Real-World Data for Safety Studies: Challenges and Opportunities From the Italian Multiple Sclerosis and Related Disorders Register.
  • 1 Aug 2026
  • Pharmacoepidemiology and drug safety
Comment on 'Comparative Effectiveness and Safety of Three Oral Antihypertensive Therapies on Maternal and Infant Outcomes in a California Medicaid Population, 2016-2020'.
  • 1 Aug 2026
  • Pharmacoepidemiology and drug safety
Climate Change and Medications: Implications for Clinical Practice, Healthcare Sustainability, and Pharmacoepidemiology
  • 31 Jul 2026
  • Pharmacoepidemiology and Drug Safety
DU\u2010Vigilance; Capturing Unsuspected Problems in Drug Utilization
  • 30 Jul 2026
  • Pharmacoepidemiology and Drug Safety
Pharmacological Therapy in Patients With Gender Dysphoria: A Cohort Study in the Lazio Region, Italy.
  • 1 Aug 2026
  • Pharmacoepidemiology and drug safety
Prenatal Exposure to Modafinil and the Risk of Major Congenital Anomalies and Other Adverse Neonatal and Pediatric Outcomes
  • 1 Aug 2026
  • Pharmacoepidemiology and Drug Safety
Real-World Data for Safety Studies: Challenges and Opportunities From the Italian Multiple Sclerosis and Related Disorders Register.
  • 1 Aug 2026
  • Pharmacoepidemiology and drug safety
Comment on 'Comparative Effectiveness and Safety of Three Oral Antihypertensive Therapies on Maternal and Infant Outcomes in a California Medicaid Population, 2016-2020'.
  • 1 Aug 2026
  • Pharmacoepidemiology and drug safety
Climate Change and Medications: Implications for Clinical Practice, Healthcare Sustainability, and Pharmacoepidemiology
  • 31 Jul 2026
  • Pharmacoepidemiology and Drug Safety
DU\u2010Vigilance; Capturing Unsuspected Problems in Drug Utilization
  • 30 Jul 2026
  • Pharmacoepidemiology and Drug Safety

FAQs on Pharmacoepidemiology and Drug Safety